Abstract:
Apparatus for adjusting a frameless window pane moved by a cable window lifter in an automobile. The apparatus includes a first guide rail which has an unlocked and a locked state, and a second guide rail. The first guide rail is freely movable to a limited degree in the unlocked state and fixed in the locked state. A window pane is connected between the first guide rail and the second guide rail such that movement of the second guide rail causes the first guide rail to move when in its unlocked state. A bolt is provided for moving the second guide rail and for locking the first guide rail.
Abstract:
The invention provides influenza proteins, including subunit proteins and immunogenic compositions that can be utilized, with or without adjuvants, as vaccines to protect against influenza infection in animal models and humans. The recombinant proteins are expressed from transformed insect cells that contain integrated copies of the appropriate expression cassettes in their genome. The invention uses a Drosophila melanogaster expression system to provide high yields of recombinant subunit proteins with native-like conformation.
Abstract:
A method for attaching a surface mountable unit to a ground surface, said method comprising (i) fixing a foundation frame, an upper portion of which is attachable to said surface mountable unit to the ground surface, and (ii) attaching the surface mountable unit to the upper portion of the foundation frame. Systems comprising combinations of foundation frames and surface mountable units and elements for use therein are also described and claimed.
Abstract:
The invention provides influenza proteins, including subunit proteins and immunogenic compositions that can be utilized, with or without adjuvants, as vaccines to protect against influenza infection in animal models and humans. The recombinant proteins are expressed from transformed insect cells that contain integrated copies of the appropriate expression cassettes in their genome. The invention uses a Drosophila melanogaster expression system to provide high yields of recombinant subunit proteins with native-like conformation.
Abstract:
Filovirus subunit protein immunogens are produced using a recombinant expression system and combined with one or more adjuvants in immunogenic formulations. The subunit proteins include GP95, GP-FL, VP40, VP24, and NP derived from Ebola Virus and Marburg Virus. Adjuvants include saponins, emulsions, alum, and dipeptidyl peptidase inhibitors. The disclosed immunogenic formulations are effective in inducing strong antibody responses directed against individual Filovirus proteins and intact Filovirus particles as well as stimulating cell-mediated immune responses to the Filoviruses.
Abstract:
The Flaviviridae comprise a number of medically important pathogens that cause significant morbidity in humans including the dengue (DEN) virus, Japanese encephalitis (JE) virus, tick-borne encephalitis virus (TBE), and yellow fever virus (YF). Flaviviruses are generally transmitted to vertebrates by chronically infected mosquito or tick vectors. The viral particle which is enveloped by host cell membranes, comprises a single positive strand genomic RNA and the structural capsid (CA), membrane (M), and envelope (E) proteins. The E and M proteins are found on the surface of the virion where they are anchored in the membrane. Mature E is glycosylated and contains functional domains responsible for cell surface attachment and intraendosomal fusion activities. Problems have arisen in the art with respect to producing recombinant forms of the E glycoprotein that retain their native configuration and attendant properties associated therewith (i.e., ability to induce neutralizing antibody responses). To date, recombinantly produced E glycoproteins have suffered from a number of limitations including improper glycosylation, folding, and disulfide bond formation. The claimed invention has addressed these concerns by providing secreted recombinant forms of the E glycoprotein that are highly immunogenic and appear to retain their native configuration. Carboxy-terminally truncated forms of E containing the amino terminal 395 amino acids and a suitable secretion signal sequence were generated in Drosophila melanogaster Schneider cell lines. Immunogenic compositions comprising these recombinant envelope glycoproteins were capable of inducing protective, neutralizing antibody responses when administered to a suitable host.
Abstract:
An apparatus comprises a container comprising a volume. The volume is configured to retain a single dose of a medication appropriate for a specific classification of a weight of a patient. A first indicia is disposed on an exterior surface of the container. The first indicia indicates a type of the medication. A second indicia is disposed on the exterior surface. The second indicia indicates the specific classification, wherein the container, pre-packaged with the single dose, is appropriate for a single use dosing of the patient having the specific weight classification.
Abstract:
A system and method is provided for cleaning patient monitoring cables including: retracting a cable using a retraction mechanism; receiving, by a housing unit, the cable; and directing, based on movement of the cable, the cable into the housing unit. The innovation may further include: providing cleaning means to the housing unit; protracting the cable; and providing drying means to the housing unit.
Abstract:
A lawn edger includes an edge guide movable between a curb-edging mode and a trench mode. A lever is connected to the edge guide and extends through an aperture of a blade guard that is positioned to cover at least a portion of the cutting blade. The lever is positionable to move the edge guide between the curb-edging mode and the trench mode. When the edge guide is in the trench mode, the lever moves from a retracted position into an extended position, thereby providing a visual directional to the user.
Abstract:
An apparatus having a container comprising a volume. The volume is configured to retain a single dose of a medication appropriate for a specific classification of a weight of a patient. A first indicia is disposed on an exterior surface of the container. The first indicia indicates a type of the medication. A second indicia is disposed on the exterior surface. The second indicia indicates the specific classification, wherein the container, pre-packaged with the single dose, is appropriate for a single use dosing of the patient having the specific classification.